FOLEY HOAG LLP

Lobbying for TONIX PHARMACEUTICALS · Manufacturer of pharmaceutical products.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $20,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Developing novel therapies and vaccines to prevent and treat central nervous system disorders.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.